Advertisement

Chromatographia

, 70:1387 | Cite as

Validity Assessment for the Results of Three Inflammatory Markers in Exhaled Breath Condensate: A Pilot Study

  • Luis M. Gonzalez-Reche
  • Dirk Schaefer
  • Thomas Göen
  • Thomas Kraus
Original

Abstract

This study was initiated to assess the validity of eicosanoid determination in exhaled breath condensate by immunoassays. The results were compared to those obtained from liquid chromatographic methods with mass spectrometric detection and with the theoretical spiked amount of condensate. Therefore, spiked exhaled breath condensate was prepared achieving samples for comparison of identical aliquots. The three most often analysed inflammatory markers in the literature, i.e. leukotriene B4, prostaglandin E2, and 8-isoprostane-prostaglandin F were selected for comparison. Three concentrations of spiked and non-spiked breath condensate matrix were examined. There was an up to 800% overestimation of the eicosanoid quantities revealed by the immunoassay kits used in this study compared to the liquid chromatographic method with mass spectrometric detection which was in line with the nominal amount spiked. Full validation of immunoassay for the determination of inflammatory markers should be performed before further interpretations and consequences will be taken from the absolute values quantified by enzyme-immunoassays. For improving the accuracy of enzyme linked immunoassay (ELISA) results a collaborative work applying ELISA and LC–MS–MS should be performed in order to spotlight the advantages of the ELISA-method.

Keywords

Column liquid chromatography–mass spectrometry Enzyme linked immunoassay Method comparison Exhaled breath condensate 

Notes

Acknowledgments

The authors want to thank Mrs. Musiol and Mrs. Dewes for the support organizing this study and Mrs. Decker for her technical assistance for the ELISA technique. Special thanks to Kathy Bischof for her editorial assistance. Furthermore, the authors would like to thank Dr. Thomas Schettgen for preparing the revision of the manuscript.

References

  1. 1.
    Gessner C, Kuhn H, Seyfarth HJ, Pankau H, Winkler J, Schauer J, Wirtz H (2001) Pneumologie 55:414CrossRefGoogle Scholar
  2. 2.
    Phillips M, Gleeson K, Hughes JMB, Greenberg J, Cataneo RN, Baker L, McVay MP (1999) Lancet 353:1930CrossRefGoogle Scholar
  3. 3.
    Hanazawa T, Kharitonov SA, Barnes PJ (2000) Am J Respir Crit Care Med 162:1273–1276Google Scholar
  4. 4.
    Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini A, Piacentini G, Zacchello F, Zanconato S (2003) Thorax 58:505–509CrossRefGoogle Scholar
  5. 5.
    Biernacki WA, Kharitonov SA, Barnes PJ (2003) Thorax 58:294–298CrossRefGoogle Scholar
  6. 6.
    Kharitonov S, Barnes P (2001) Am J Respir Crit Care Med 163:1693–1722Google Scholar
  7. 7.
    Barnes PJ, Chung KF, Page CP (1998) Pharmacol Rev 50:515–596Google Scholar
  8. 8.
    Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA (2003) Am J Respir Crit Care Med 167:1109–1112CrossRefGoogle Scholar
  9. 9.
    Repine JE, Bast A, Lankhorst I (1997) Am J Respir Crit Care Med 156:341–357Google Scholar
  10. 10.
    Czebe K, Barta I, Antus B, Valyon M, Horvath I, Kullmann T (2008) Respir Med 102:720–725CrossRefGoogle Scholar
  11. 11.
    Conventz A, Musiol A, Brodowsky C, Müller-Lux A, Dewes P, Kraus T, Schettgen T (2007) J Chromatogr B 860:78–85CrossRefGoogle Scholar
  12. 12.
    Montuschi P, Martello S, Felli M, Mondino C, Chiarotti M (2004) Rapid Commun Mass Spectrom 18:2723–2729CrossRefGoogle Scholar
  13. 13.
    Carpenter CT, Price PV, Christman BW (1998) Chest 114:1653–1659CrossRefGoogle Scholar
  14. 14.
    Hyde RW (2002) Am J Respir Crit Care Med 165:561–562Google Scholar
  15. 15.
    Gonzalez-Reche LM, Musiol AK, Muller-Lux A, Kraus T, Goen T (2006) J Occup Med Toxicol 1:5CrossRefGoogle Scholar
  16. 16.
    Montuschi P, Ragazzoni E, Valente S, Corbo G, Mondino C, Ciappi G, Ciabattoni G (2003) Inflamm Res 52:502–507CrossRefGoogle Scholar
  17. 17.
    Effros RM, Su J, Casaburi R, Shaker R, Biller J, Dunning M (2005) Curr Opin Pulm Med 11:135–139CrossRefGoogle Scholar
  18. 18.
    Horváth I, Hunt J, Barnes P, Alving K, Antczak A, Baraldi E, Becher G, Beurden Mv, Corradi M, Dekhuijzen R, Dweik R, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho L, Hohlfeld J, Jöbsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin A, Redington A, Reinhold P, Rensen Ev, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H (2005) ATS/ERS task force on exhaled breath condensate. Eur Respir J 26:523–548CrossRefGoogle Scholar

Copyright information

© Vieweg+Teubner | GWV Fachverlage GmbH 2009

Authors and Affiliations

  • Luis M. Gonzalez-Reche
    • 1
  • Dirk Schaefer
    • 2
  • Thomas Göen
    • 1
    • 3
  • Thomas Kraus
    • 1
  1. 1.Institute and Outpatient-Clinic for Occupational and Social MedicineMedical Faculty, RWTH Aachen UniversityAachenGermany
  2. 2.Medizinische Klinik III, Division of AllergologyFriedrich-Alexander-Universität Erlangen-NürnbergErlangenGermany
  3. 3.Institute of Occupational, Social and Environmental MedicineFriedrich-Alexander-Universität Erlangen-NürnbergErlangenGermany

Personalised recommendations